Wells Fargo
ISEE

Wells Fargo’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Wells Fargo’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,000
Closed -$585K – 7754
2021
Q2 		$585K Buy
+100,000
New +$645K ﹤0.01% 4540

Wells Fargo's ISEE Position: Q3 2023 in Review

Wells Fargo sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 98,896 shares — an estimated $3.89M sold.

Wells Fargo first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $18M in Q2 2016. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Wells Fargo reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 98,896 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.89M.
  • Wells Fargo first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Wells Fargo's IVERIC bio, Inc. Common Stock position peaked at $18M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.